Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylaxis of Venous Thromboembolic Disease With Low Molecular Weight (LMWH) (TINzaparin) in Patients With Metastatic Colorectal Cancer Who Start the First Line of Treatment.

NCT05625932 is registered in ClinicalTrials.gov with Galician Research Group on Digestive Tumors as lead sponsor.

NCT NCT05625932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05625932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylaxis of Venous Thromboembolic Disease With Low Molecular Weight (LMWH) (TINzaparin) in Patients With Metastatic Colorectal Cancer Who Start the First Line of Treatment.
Lead sponsor
Galician Research Group on Digestive Tumors
Phase
Phase 3
Overall status
Completed
Start date
March 2, 2023
Completion date
June 4, 2025
Enrollment
232 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic, thromboembolism